The Neurointervention Center

Filter Your Results

 

News

 

Three Rivers Medical's Rio Embolization Coil System Receives CE Mark Approval

February 20, 2018-Three Rivers Medical, Inc. announced that it has received CE Mark approval for the Rio embolization coil system, which is indicated for endovascular emboliza…

Perflow Medical Announces Financing to Support Cerebral Aneurysm Technology; Progress With Stroke Platform

February 15, 2018 -- Perflow Medical has announced the closing of $12 million in financing aimed at supporting commercialization of its Stream Net device in Europe and other c…

Stryker's Trevo Retriever Now Indicated for Treating Stroke Up to 24 Hours From Symptom Onset

February 15, 2018 -- Stryker has announced that its Trevo Retriever device has received an expanded indication from the US Food and Drug Administration (FDA) as a front-line t…

FDA Approves Marketing of Viz.ai's Stroke Identification Software Application

February 13, 2018 -- The US Food and Drug Administration (FDA) announced that it has permitted marketing of Viz.ai’s Contact application, a clinical decision support sof…

Postmarket WEAVE Study Presented for Stryker's Wingspan Stent System to Treat Intracranial Atherosclerotic Disease

January 30, 2018 -- Stryker announced that results from WEAVE, the postmarket surveillance study of the company's Wingspan stent system, were presented at the ISC 2018: th…

Certification for Thrombectomy-Capable Stroke Centers Offered by Joint Commission and AHA/ASA

January 28, 2018 -- The Joint Commission, in collaboration with the American Heart Association/American Stroke Association (AHA/ASA) announced the Certification for Thrombecto…

DEFUSE 3 Shows Effectiveness of Stroke Thrombectomy to 16 Hours, Utility of Perfusion Imaging

January 24, 2018 -- The National Institutes of Health (NIH) announced that the results of the DEFUSE 3 trial were presented at the International Stroke Conference 2018, held J…

European PROMISE Study of Penumbra System Presented at International Stroke Conference

January 25, 2018 -- Penumbra, Inc. announced results of the company-sponsored PROMISE study, a European registry evaluating the company's Ace reperfusion catheters and dem…

 

advertisement

2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.